Manning & Napier Advisors’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
VCM
VPM
Manning & Napier Advisors's LLY Position: Q1 2026 in Review
Manning & Napier Advisors increased its Eli Lilly (LLY) stake by 9.8% in Q1 2026, buying an estimated $4.05K and bringing the position to 45 shares worth $39.9K. The position accounts for ﹤0.01% of the portfolio, ranked #371.
Manning & Napier Advisors first reported a position in LLY in Q2 2013 and has held it in 22 quarters since. The position peaked at $382M in Q2 2015. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.
- Manning & Napier Advisors held 45 shares of Eli Lilly worth $39.9K as of Q1 2026.
- Manning & Napier Advisors bought 4 Eli Lilly shares in Q1 2026, an estimated $4.05K.
- Eli Lilly made up ﹤0.01% of Manning & Napier Advisors's portfolio in Q1 2026, its #371 holding.
- Manning & Napier Advisors first reported a position in Eli Lilly in Q2 2013 and has held it in 22 quarters since.
- Manning & Napier Advisors's Eli Lilly position peaked at $382M in Q2 2015.
- 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.
Based on Manning & Napier Advisors's 13F filing for Q1 2026, filed 30 Apr 2026.